4th Quarter - Report
VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Time-Temperature Indicators for Vaccines and Pharmaceuticals technology. H.R.1483, Drug Safety Enhancement Act of 2011, Cold chain temperature related issues. Cold Chain Initiative related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M CRUM | — |
| MARDA ROBILLARD | — |
| H STEWART VAN SCOYOC | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.